Report

reporttype1Version of Safety Report ID1receivedateformat102transmissiondateformat102fulfillexpeditecriteria1Safety Report ID10029441serious1Date Last Updated22/03/2014receiptdateformat102companynumbPHEH2014US005546occurcountryUSseriousnessother1duplicate1Date Received22/03/2014transmissiondate02/10/2014primarysourcecountryUS

Primary Source

reportercountryUSqualification1

Patient

SexMale

Reaction

1)

reactionmeddraversionpt17.0ReactionHypersensitivityOutcomeUnknown

2)

reactionmeddraversionpt17.0ReactionAnaphylactic reactionOutcomeUnknown

3)

reactionmeddraversionpt17.0ReactionDyspnoeaOutcomeUnknown

4)

reactionmeddraversionpt17.0ReactionPharyngeal oedemaOutcomeUnknown

5)

reactionmeddraversionpt17.0ReactionOedema mouthOutcomeUnknown

6)

reactionmeddraversionpt17.0ReactionAbdominal painOutcomeNot recovered/not resolved

7)

reactionmeddraversionpt17.0ReactionNauseaOutcomeNot recovered/not resolved

Drug

1)

drugcharacterization1medicinalproductFOCALIN XRdrugauthorizationnumb021802drugstructuredosagenumb30drugstructuredosageunit003drugdosagetext30 MG, DAILY (20 MG QD AND 10 MG QD)drugdosageformExtended Release Capsulesdrugadministrationroute048drugindicationATTENTION DEFICIT/HYPERACTIVITY DISORDERactiondrug5drugrecurreadministration3

openFDA Info on Medication

Application NumberNDA021802Brand NameFOCALIN XRGeneric NameDEXMETHYLPHENIDATE HYDROCHLORIDEManufacturersNovartis Pharmaceuticals Corporationproduct_ndc 0078-0430, 0078-0433, 0078-0608, 0078-0609, 0078-0434, 0078-0493, 0078-0431, 007 ... Product TypeHUMAN PRESCRIPTION DRUGRouteORALActive IngredientsDEXMETHYLPHENIDATE HYDROCHLORIDERXCUI 899439, 899441, 899461, 899463, 899485, 899487, 899495, 899497, 899511, 899513, ... spl_id9cb2eba9-6583-42db-8a1a-380c032898fbspl_set_id1a1da905-42a0-4748-9c39-67eca45decccPackage NDC 0078-0433-05, 0078-0608-05, 0078-0609-05, 0078-0434-05, 0078-0493-05, 0078-0430- ... UNII1678OK0E08

2)

drugcharacterization2medicinalproductVITAMIN DdrugdosagetextUNK UKN, UNKactiondrug5drugrecurreadministration3

openFDA Info on Medication

Application NumberANDA090455Brand NameVITAMIN DGeneric NameERGOCALCIFEROLManufacturersStrides Pharma Science Limitedproduct_ndc64380-737Product TypeHUMAN PRESCRIPTION DRUGRouteORALActive IngredientsERGOCALCIFEROLRXCUI1367410spl_id08a99dff-5765-49b0-b289-4e854d3c6725spl_set_id2c4c0a36-12cf-444d-9d57-de983eef4d36Package NDC64380-737-06, 64380-737-25NUIM0007651, N0000175909Chemical StructureErgocalciferols [CS]Established Pharmacologic ClassProvitamin D2 Compound [EPC]UNIIVS041H42XC

3)

drugcharacterization2medicinalproductCALCIUMdrugdosagetextUNK UKN, UNKactiondrug5drugrecurreadministration3

openFDA Info on Medication

Brand Name P D ALL, ONLYCAL, RESTO L, P D M, RESTORATION TREATMENT, TALL G U, C P RE, D T B ... Generic NameCALCIUMManufacturerscoexleaders co.,ltd.product_ndc 81445-0002, 81445-0005, 81445-0006, 81445-0003, 81445-0001, 81445-0008, 81445-00 ... Product TypeHUMAN OTC DRUGRouteORALActive IngredientsCALCIUMspl_id b9e7d910-8df8-ca9a-e053-2995a90a0d05, b9eb3dea-4f3e-1d23-e053-2995a90a4eb2, b9eb ... spl_set_id b9e7d869-d218-d60c-e053-2995a90af542, b9eb3cc9-e340-c77d-e053-2995a90a1628, b9eb ... Package NDC 81445-0002-1, 81445-0005-1, 81445-0006-1, 81445-0003-1, 81445-0001-1, 81445-0008 ... NUIM0003153, N0000175901, N0000175597, N0000020074Chemical StructureCalcium [CS]Established Pharmacologic ClassCalcium [EPC], Phosphate Binder [EPC]Mechanism of ActionPhosphate Chelating Activity [MoA]UNIISY7Q814VUP

4)

drugcharacterization2medicinalproductZOLOFTdrugdosagetextUNK UKN, UNKactiondrug5drugrecurreadministration3

openFDA Info on Medication

Application NumberNDA020990, NDA019839Brand NameZOLOFTGeneric NameSERTRALINE HYDROCHLORIDEManufacturersRoerigproduct_ndc0049-0050, 0049-4960, 0049-4900, 0049-4910Product TypeHUMAN PRESCRIPTION DRUGRouteORALActive IngredientsSERTRALINE HYDROCHLORIDERXCUI208149, 208161, 212233, 312938, 312940, 312941, 861064, 861066spl_id665a145d-44fb-4fef-a3c1-2aac26e0715cspl_set_idfe9e8b7d-61ea-409d-84aa-3ebd79a046b5Package NDC 0049-4960-30, 0049-4960-50, 0049-4900-30, 0049-4900-66, 0049-4900-73, 0049-4900- ... UNIIUTI8907Y6X

5)

drugcharacterization2medicinalproductEPIPENdrugdosagetextUNK UKN, UNKactiondrug5drugrecurreadministration3

openFDA Info on Medication

Application NumberNDA019430Brand NameEPIPENGeneric NameEPINEPHRINEManufacturersMylan Specialty L.P.product_ndc49502-500, 49502-501Product TypeHUMAN PRESCRIPTION DRUGRouteINTRAMUSCULARActive IngredientsEPINEPHRINERXCUI727316, 727347, 727386, 1870207spl_id55bb7452-535c-4497-865a-29f3fb72d3ffspl_set_id7560c201-9246-487c-a13b-6295db04274aPackage NDC 49502-500-01, 49502-500-02, 49502-500-92, 49502-501-01, 49502-501-02, 49502-501- ... NUIN0000000209, N0000000245, N0000175552, N0000175555, N0000175570, M0003647Mechanism of ActionAdrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA]Established Pharmacologic Class alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC], Catecholamine [EP ... Chemical StructureCatecholamines [CS]UNIIYKH834O4BH

6)

drugcharacterization2medicinalproductADDERALLdrugdosagetextUNK UKN, UNKactiondrug5drugrecurreadministration3

openFDA Info on Medication

Application NumberANDA040422, NDA021303Brand NameADDERALL, ADDERALL XRGeneric Name DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, ... ManufacturersTeva Pharmaceuticals USA, Inc., Takeda Pharmaceuticals America, Inc.product_ndc 57844-105, 57844-117, 57844-110, 57844-112, 57844-115, 57844-120, 57844-130, 540 ... Product TypeHUMAN PRESCRIPTION DRUGRouteORALActive Ingredients DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMI ... RXCUI 541363, 541365, 541878, 541879, 541892, 541894, 577957, 577960, 577961, 577962, ... spl_ide9cd0754-917c-4545-8963-e0b5b8fe544a, 05c01190-093d-41b3-8fe6-4ad8d6e2aee3spl_set_idf22635fe-821d-4cde-aa12-419f8b53db81, aff45863-ffe1-4d4f-8acf-c7081512a6c0Package NDC 57844-105-01, 57844-117-01, 57844-110-01, 57844-112-01, 57844-115-01, 57844-120- ... UNIIJJ768O327N, G83415V073, 6DPV8NK46S, O1ZPV620O4

7)

drugcharacterization2medicinalproductINSULINdrugdosagetextUNK UKN, UNKactiondrug5drugrecurreadministration3

Report Duplicate

duplicatesourceNOVARTISduplicatenumbPHEH2014US005546

Receiver

receivertype6receiverorganizationFDA

Sender

sendertype2senderorganizationFDA-Public Use

Adverse Event Report

Report

Primary Source

Patient

Reaction

1)

2)

3)

4)

5)

6)

7)

Drug

1)

openFDA Info on Medication

2)

openFDA Info on Medication

3)

openFDA Info on Medication

4)

openFDA Info on Medication

5)

openFDA Info on Medication

6)

openFDA Info on Medication

7)

Report Duplicate

Receiver

Sender

Media

Newsletter

Follow us

Connect with us